peptides cjc 1295 and ipamorelin results Peptide Therapy CJC-1295 Ipamorelin Before and After

doi: 10.1089/ars.2010.3496 97 GhatiA.DamP.TasdemirD.KatiA.SellamiH.SezginG

Bellis, G

Clinical Evidence HIV patients: 26-week trials show 20% reduction in abdominal fat Metabolic syndrome patients: Improvements in triglycerides, liver fat, and insulin sensitivity Ideal Candidates for Tesamorelin People with visceral obesity Patients with metabolic syndrome or insulin resistance Individuals able to commit to daily injections and lab monitoring Ipamorelin: Gentle Growth Hormone Booster Ipamorelin is a selective ghrelin receptor agonist that stimulates GH without significantly affecting cortisol, prolactin, or ACTH

This tweak in peptide science makes it possible to extend the effects of natural processes, a game-changer for those looking to optimize performance and longevity

It may also help limit the damage from fatty liver disease